Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0346249 USE OF AMITIFADINE, (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE IN METHODS AND COMPOSITIONS WITH...
The present invention relates to (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and pharmaceutically acceptable active salts, polymorphs, glycosylated...
2016/0346248 Combined Acetylcholinesterase Inhibitor and Quaternary Ammonium Antimuscarinic Therapy to Alter Progression of...
A method administers quaternary ammonium anti-cholinergic muscarinic receptor antagonists in combination with acetyl-cholinesterase inhibitors to treat either...
2016/0346247 GELATINASE INHIBITORS AND PRODRUGS
The invention provides compounds, compositions, and methods for the treatment of diseases, disorders, or conditions that are modulated by matrix...
2016/0346246 METHODS FOR THE TREATMENT OF LUNG DISEASES WITH MAST CELL STABILIZERS
Methods for the treatment of lung diseases with mast cell stabilizers are provided.
2016/0346245 MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
2016/0346244 METAP2 INHIBITORS AND METHODS OF TREATING OBESITY
The present invention relates to modified or polymer conjugated MetAP2 inhibitors. The present invention also relates to methods of preventing, inducing,...
2016/0346243 DIETHYL-[6-(4-HYDROXYCARBAMOYL-PHENYL-CARBAMOYLOXY-METHYL)-NAPHTHALEN-2-YL- -METHYL]-AMMONIUM CHLORIDE FOR USE...
The present invention relates to a method for treating muscular dystrophy which comprises administering ...
2016/0346242 COMPOSITION COMPRISING EPA AND DHA ETHYLESTER FOR PARENTERAL ADMINISTRATION
Described herein are compositions for parenteral administration that include an aqueous phase and 5 to 30%, by weight, of an oil phase, based on the total...
2016/0346241 ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
The present invention provides an oral pharmaceutical composition of isotretinoin having enhanced bioavailability, wherein said composition is in the form of a...
2016/0346240 METHODS OF CHEMOTHERAPY USING CHEMOTHERAPEUTIC AGENTS BASED ON BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS
Compositions and methods for protecting normal, healthy cells during chemotherapy are disclosed. The methods include administering one or more compounds that...
2016/0346239 HEMOSTATIC COMPOSITION AND DEVICE
A hemostatic composition comprises calcium alginate, a chitosan, epsilon-aminocaproic acid, an acid selected from aminomethylbenzoic acid and tranexamic acid,...
2016/0346238 Compositions and Methods of Use of -hydroxy--methylbutyrate (HMB) for Decreasing Fat Mass
The present invention provides a composition comprising HMB. Methods of administering HMB to an animal are also described. HMB is administered to enhance or...
2016/0346237 ACETIC ACID/THYMOL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF ONYCHOMYCOSIS
A composition comprising from about 1 weight part to about 10 weight parts a saturated carboxylic acid having from 2 to about 20 carbon atoms; front about 0.1...
2016/0346236 COMPOSITIONS AND METHODS FOR MODULATING HEXM1 EXPRESSION
The potency of a series of Hexamethylene bis-acetamide (HMBA) derivatives of formula I, that induce Hexamethylene bis-acetamide inducible protein 1 (HEXIM1)...
2016/0346235 ORAL LIQUID COMPOSITIONS OF GUANFACINE
The present invention relates to oral liquid compositions of guanfacine. The liquid. compositions can be immediate release or extended release compositions....
2016/0346234 TREATMENT OF RESPIRATORY DISORDERS USING ROR-GAMMA INHIBITORS
The present patent application relates to treatment of a respiratory disorder using retinoid-related orphan receptor gamma t (ROR-gamma) modulators....
2016/0346233 EXTENDED RELEASE LIQUID COMPOSITIONS OF GUANFACINE
The present invention relates to extended release liquid compositions of guanfacine. The extended release liquid compositions of the present invention are...
2016/0346232 METHODS OF TREATING PRADER-WILLI SYNDROME
Methods of treating Prader-Willi syndrome in a subject in need of treatment are provided. The methods include administering to the subject an effective amount...
2016/0346231 Disulfiram Compositions and Treatments for Brain Tumors
The present disclosure provides a compositions and methods of inhibiting 06-methylguanine DNA methyltransferase in human tumor cells by providing an effective...
2016/0346230 Endoxifen Compositions And Methods
The present invention provides compositions containing endoxifen, formulations and liposomes of endoxifen, methods of preparation of such agents and...
2016/0346229 Semisolid Aqueous Pharmaceutical Composition Containing Tapentadol
A semisolid aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof.
2016/0346228 Use of 1-phenyl-3-dimethylaminopropane Compounds for Treating Rheumatoid Pain
The use of 1-phenyl-3-dimethylaminopropane compounds for the treatment of rheumatoid pain, especially rheumatoid arthritic pain, very especially preferably...
2016/0346227 MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release...
2016/0346226 Therapeutic Applications Of Prenylated Stilbenoids Against Rotavirus Infections
The present invention relates generally to the treatment of virus infections. More specifically, the present invention relates to compositions and methods to...
2016/0346225 METHOD OF PREPARING INGESTIBLE MULTI-SHEET UNIT HAVING PREDETERMINED FUNCTIONS AND COMBINATIONS
A combination of sheets can be combined into an ingestible unit. The individual sheets can be prepared to have one or more functionalities, such as providing a...
2016/0346224 COMPOSITIONS AND METHODS FOR REDUCING VISUAL LOSS
The described invention provides a method for reducing visual loss and for treating one or more of adverse consequence of an eye disease, including abnormal...
2016/0346223 INDIVIDUALLY-PACKAGED WIPES FOR ENHANCING SEXUAL INTERCOURSE
The present invention relates to a sealed package containing one wipe, wherein the one wipe comprises a carrier and an active ingredient impregnated therein,...
2016/0346222 Compositions and Methods for the Delivery of Therapeutics
The present invention provides compositions and methods for the delivery of antivirals to a cell or subject.
2016/0346221 PHOSPHOLIPID-COATED THERAPEUTIC AGENT NANOPARTICLES AND RELATED METHODS
Phospholipid-coated nanoparticles containing a therapeutic agent, compositions that include the nanoparticles, and methods for making and using the...
2016/0346220 PHOSPHOLIPID-COATED THERAPEUTIC AGENT NANOPARTICLES AND RELATED METHODS
Phospholipid-coated nanoparticles containing a therapeutic agent, compositions that include the nanoparticles, and methods for making and using the...
2016/0346219 PHOSPHOLIPID-COATED THERAPEUTIC AGENT NANOPARTICLES AND RELATED METHODS
Phospholipid-coated nanoparticles containing a therapeutic agent, compositions that include the nanoparticles, and methods for making and using the...
2016/0346218 HYBRID HOLLOW MICROCAPSULE, SCAFFOLD FOR SOFT TISSUE INCLUDING SAME, AND METHODS OF PREPARING SAME
Disclosed is a method of preparing a hollow microcapsule using freezing of macroporous materials including a crosslinked inorganic particle network capable of...
2016/0346217 POLYDOPAMINE-COATED CAPSULES
One aspect of the invention is a polymer material comprising a capsule coated with PDA. In certain embodiments, the capsule encapsulates a functional agent....
2016/0346216 COMPOSITION AND METHOD FOR AIDING SLEEP
Described is a controlled-release formulation for treating disturbed sleep or insomnia in a subject. The formulation is formulated to release a compound or...
2016/0346215 PHARMACEUTICAL TABLET CONTAINING A LIQUID FILLED CAPSULE
In one aspect, the present invention features a tablet including a compressed core and a liquid filled capsule, wherein the compressed core includes a first...
2016/0346214 TABLET FORMULATION FOR CGRP ACTIVE COMPOUNDS
The present invention is directed to compositions comprising an extrudate or solid solution of a compound, or a salt thereof, of Formula I (API): Formula I,...
2016/0346213 COMPOSITE FORMULATION FOR ORAL ADMINISTRATION COMPRISING EZETIMIBE AND ROSUVASTATIN
Provided are a solid composite formulation for oral administration, the solid composite formulation including: an ezetimibe granules-part including ezetimibe,...
2016/0346212 METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES
Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to...
2016/0346211 BIOERODIBLE SILICON-BASED DELIVERY VEHICLES FOR DELIVERY OF THERAPEUTIC AGENTS
This invention discloses bioerodible delivery compositions for delivering peptide therapeutic agents. The delivery compositions comprise a porous silicon-based...
2016/0346210 MEDICAL MAGNETIC PELLETS
A medical magnetic pellet is provided. The magnetic pellet includes a porous matrix and magnetic powder distributed in the porous matrix. Moreover, an active...
2016/0346209 Methods for Superdisintegrant-Based Composite Particles for Dispersion and Dissolution of Active Pharmaceutical...
The present disclosure provides improved systems and methods utilizing colloidal/ultrafine superdisintegrant-based composite particles for dispersion and/or...
2016/0346208 DUAL RESPONSIVE BRAIN TARGETED NANOPARTICLES AND THEIR APPLICATIONS
The preparation of dual functionalized nanoparticles is generally provided along with their application. The dual functionalized nanoparticles provide dual...
2016/0346207 Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists
The present invention belongs to the field of pharmaceutical industry and relates to a solid pharmaceutical composition comprising androgen receptor...
2016/0346206 Assisted Particle Size Reduction Process
A new scalable process to control the particle size and the particle size distribution, comprising5 steps: (i) suspension preparation in a mixture of solvents...
2016/0346205 LIPOSOME LOADING
Provided herein is technology relating to incorporation of drugs into liposomes and particularly, but not exclusively, to methods for incorporating drugs into...
2016/0346204 NANOSCALE CARRIERS FOR THE DELIVERY OR CO-DELIVERY OF CHEMOTHERAPEUTICS, NUCLEIC ACIDS AND PHOTOSENSITIZERS
Nanoscale coordination polymer nanoparticles for the co-delivery of multiple therapeutic agents are described. The multiple therapeutic agents can include a...
2016/0346203 MEANS AND METHODS FOR OCULAR DRUG DELIVERY
The invention relates to compositions and methods that utilize polymeric nanoparticles to deliver a therapeutic compound to ocular cells or ocular tissue....
2016/0346202 Composition for Vectorizing an Anti-Cancer Agent
The invention relates to a stable water-in-oil emulsion composition containing: 20% to 40% (v/v) aqueous phase in the form of droplets and containing an...
2016/0346201 NANOSUSPENSION OF NATURAL MATERIALS AND PREPARATION METHOD THEREOF
The present disclosure relates to a method for the preparation of a nanosuspension of at least one natural material, wherein the method comprises the steps of...
2016/0346200 NOVEL PHARMACEUTICAL FORMULATIONS
The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders. In certain...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.